We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Phage Therapy Trial Launched Following FDA Approval

News   Feb 25, 2019 | Original Story by Scott LaFee and Heather Buschman for the University of California San Diego Health.

 
Phage Therapy Trial Launched Following FDA Approval

Colorized micrograph of bacteriophages (green) attacking a bacterium. Credit: Thomas Deerinck, National Center for Microscopy and Imaging Research, UC San Diego.

 
 
Advertisement
 

RELATED ARTICLES

New Compound Traps the Malaria Parasite Inside Cells

News

Researchers have designed a drug-like compound that effectively blocks a critical step in the malaria parasite life cycle and are working to develop this compound into a potential malaria treatment.

READ MORE

Researchers Decode the "Language" of Immune Cells

News

Scientists have identified six "words" that specific immune cells use to call up immune defense genes. This is an important step toward understanding the language the body uses to marshal responses to threats.

READ MORE

New Molecule Could Enable Use of THC To Fight Pain Without the Side Effects

News

Researchers have developed a peptide that, in mice, allowed the main component of Cannabis sativa to fight chronic pain without impacting memory and other cognitive functions.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE